The report "Excipients in Pharmaceuticals: Global Markets to 2029" looks at the growing demand for inactive ingredients in medications. The market for Excipients, which enhance drug stability and delivery, is growing rapidly, driven by new technologies and healthcare needs. BOSTON , Oct.
28, 2024 /PRNewswire/ -- According to the latest BCC Research study, Excipients in Pharmaceuticals: Global Markets to 2029 , the market for these ingredients was valued at $9.2 billion in 2023, and is expected to grow from $9.7 billion in 2024 to $12.
4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1%. This report offers a detailed analysis of the market for pharmaceutical excipients, focusing on the competitive landscape and the revenues and product portfolio of leading companies.
It examines trends, challenges, and opportunities, along with market projections through 2029. The report segments the market by excipient types—organic, inorganic, and USP water—as well as specific categories such as carbohydrates (cellulose, sugars, starch), and calcium salts. It also evaluates the three dosage forms (solid, liquid, semisolid) and administration routes (oral, injectable, topical).
The insights will help pharmaceutical companies, contract formulators and research institutes make informed decisions. Interesting and surprising facts Excipients ensure that active pharmaceutical ingredients (APIs) can work effectively at their target sites. Excipients make up 80% to 90% o.
